SCHEMBL7351908

SCHEMBL7351908

COc1cc2c(cc1OC)S(=O)(=O)N(Cc1ccccc1)C(C(=O)O)C2

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 5/20 0.68
AGTR2 P50052 1/20 0.46
ACE P12821 2/20 0.43
BCHE P06276 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8499745 0.91 CAPN1 (0.66) CAPN1AGTR2BCHE
SCHEMBL8499887 0.78 CAPN1 (0.57) CAPN1AGTR2ACE
SCHEMBL27938420 0.74 SIGMAR1 (0.47) CAPN1AGTR2ACEBCHE
SCHEMBL8498396 0.69 CAPN1 (0.53) CAPN1
SCHEMBL10851383 0.68 PDE4B (0.61) AGTR2ACE
SCHEMBL8498676 0.67 CAPN1 (0.63) CAPN1ACE
SCHEMBL29695296 0.65 ACHE (0.63)
SCHEMBL15903276 0.65 BCHE (0.65) BCHE
SCHEMBL23464974 0.65 GRM6 (0.56) AGTR2ACE
SCHEMBL6488253 0.65 GRM6 (0.56) AGTR2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938477-A4 BENZOTHIAZO AND RELATED HETEROCYCLIC GROUP-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON INC (US) 1999-12-29 EP disclosed
US-5952328-A MAY BE USED TO ALLEVIATE, MEDIATE, REDUCE AND/OR PREVENT DISORDERS WHICH ARE ASSOCIATED WITH ABNORMAL AND/OR ABERRANT ACTIVITY OF CYSTEINE PROTEASES AND/OR SERINE PROTEASES CEPHALON, INC. (US) 1999-09-14 US disclosed
EP-0938477-A1 BENZOTHIAZO AND RELATED HETEROCYCLIC GROUP-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1999-09-01 EP disclosed
WO-1998021186-A1 BENZOTHIAZO AND RELATED HETEROCYCLIC GROUP-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1998-05-22 WO disclosed